探索12个月时BOOST干预措施对行走障碍的调解者:因果调解分析
Lianne Wood1, Christine Comer2, Paul Newell1
1Department of Public Health and Sports Science, University of Exeter, Exeter, UK.
Journal of physiotherapy
|June 21, 2025
概括
通过提高步行自信和减少疼痛,BOOST干预改善了老年人的行走障碍. 这些因素是实现更好的流动性结果的关键调解者.
科学领域:
- 老年学是一门学科.
- 康复医学 康复医学 康复医学
- 临床试验 临床试验
背景情况:
- 神经性听显著影响老年人的运动能力.
- 了解步行改善的媒介对于有效的干预至关重要.
研究的目的:
- 调查步行障碍的改善是否通过步行自信,能力,避免恐惧,疼痛严重程度或身体表现来调解.
- 分析BOOST干预影响行走障碍的因果途径.
主要方法:
- 对65岁及以上的社区成年人进行了因果调解分析.
- 定向非循环图识别了治疗前的混因素,并归算了缺失的数据.
- 通过每个调解者估计了自然间接效应 (NIEs).
主要成果:
- 在12个月后,BOOST干预显示出改善步行距离的趋势.
- 通过所有媒介的综合自然间接效应有利于干预 (OR 0.71).
- 步行信心的改善 (NIE OR 0.87) 和疼痛严重程度的降低 (NIE OR 0.90) 是显著的调解者.
结论:
- 布斯干预措施提高了老年人的行走障碍与神经性语音障碍.
- 步行自信和疼痛严重程度是干预措施对移动性影响的主要调解者.
- 临床医生应专注于提高行走信心和减轻疼痛的干预措施,以获得更好的长期结果.
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.


